ProKidney Corp.
PROK
$1.33
-$0.08-5.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 55.22% | 190.52% | 1,075.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.22% | 190.52% | 1,075.00% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 55.22% | 190.52% | 1,075.00% | -- | -- |
| SG&A Expenses | -10.54% | -6.76% | 2.00% | 27.87% | 23.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.67% | -5.85% | -7.02% | 13.67% | 14.86% |
| Operating Income | -0.51% | 6.18% | 7.48% | -13.18% | -14.52% |
| Income Before Tax | -1.91% | 5.78% | 7.77% | -14.30% | -22.34% |
| Income Tax Expenses | -228.29% | -68.57% | 169.23% | 653.77% | -78.67% |
| Earnings from Continuing Operations | -0.79% | 5.83% | 7.18% | -16.60% | -19.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -11.29% | -13.88% | -19.11% | -3.03% | -6.93% |
| Net Income | -16.12% | -5.64% | -12.75% | -55.74% | -87.35% |
| EBIT | -0.51% | 6.18% | 7.48% | -13.18% | -14.52% |
| EBITDA | -0.10% | 6.80% | 8.38% | -12.73% | -13.89% |
| EPS Basic | 2.54% | 12.95% | 17.76% | 1.39% | 4.10% |
| Normalized Basic EPS | -161.40% | -661.07% | -232.38% | -145.16% | -122.53% |
| EPS Diluted | 2.54% | 12.95% | 17.76% | 1.39% | 4.10% |
| Normalized Diluted EPS | -161.40% | -661.07% | -232.38% | -145.16% | -122.53% |
| Average Basic Shares Outstanding | 18.04% | 19.99% | 36.41% | 60.18% | 96.49% |
| Average Diluted Shares Outstanding | 18.04% | 19.99% | 36.41% | 60.18% | 96.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |